Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,780 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Delayed Toxicities Post-CAR-T

NCT07665307

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations
  • UCSF Medical Center San Francisco, California, United States
  • Mount Sinai New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

OLE Study With Filgotinib in JIA

NCT07553182

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations
  • Bicetre Hospital Le Kremlin-Bicêtre, France
  • Hamburger Zentrum für Kinder- und Jugendrheumatologie Hamburg, Germany
  • Asklepios Klinik Sankt Augustin GmbH Sankt Augustin, Germany
  • Great Ormond Street Hospital for Children London, United Kingdom
View Trial Details
Recruiting

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

NCT06977724

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dry Eye Syndrome, +7 more
Locations
  • Life Clinical Trials - Colonial Drive - Margate /ID# 276050 Margate, Florida, United States
  • Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 275836 Tampa, Florida, United States
  • Integrative Rheumatology of South Texas - Harlingen /ID# 276458 Harlingen, Texas, United States
  • Les Hopitaux Universitaires de Strasbourg - Hopital de Hautepierre /ID# 272692 Strasbourg, Alsace, France
View Trial Details
Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

NCT07088068

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Scottsdale Clinical Trials- Site Number : 8400044 Scottsdale, Arizona, United States
  • Marvel Clinical Research- Site Number : 8400042 Huntington Beach, California, United States
  • University of California San Francisco - Mission Bay- Site Number : 8400011 San Francisco, California, United States
  • Barbara Davis Center for Childhood Diabetes- Site Number : 8400031 Aurora, Colorado, United States
View all 162 locations
View Trial Details
Recruiting

CD45BE-HSPC + CART-45 Cells

NCT07451054

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

IASO-782 in Systemic Lupus Erythematosus

NCT07483346

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine Hangzhou, Zhejiang, China
  • The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • Huzhou Central Hospital Huzhou, Zhejiang, China
  • The First Hospital of Jiaxing Jiaxing, Zhejiang, China
View Trial Details
Recruiting

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

NCT07266831

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Ruane Clinical Research Group, Inc. ( Site 1513) Los Angeles, California, United States
  • Vivent Health ( Site 1519) Denver, Colorado, United States
  • Whitman-Walker Institute ( Site 1538) Washington D.C., District of Columbia, United States
  • Midway Immunology and Research Center ( Site 1503) Ft. Pierce, Florida, United States
View all 55 locations
View Trial Details
Recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

NCT06287229

Conditions
B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

NCT06919354

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California - San Diego San Diego, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • University of Florida - Gainesville Gainesville, Florida, United States
View Trial Details
Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NCT06697184

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details

Related conditions